Search keyWord :

TRENDINGJan 15, 2025

Timekettle CEO Leal Tian Joins Elite Panel on AI Innovation at Microsoft's Event During CES 2025

LAS VEGAS,Jan. 14,2025-- During CES 2025,Microsoft Greater China held a specialized event themed "Be AI Ready,Win Globally," focusing on empowering Chinese enterprises that are expanding in

REVIEWSJan 15, 2025

Korea's Leading Indie Beauty Brand d'Alba, Reaches New Heights Globally with 210% Overseas Sales Surge

SEOUL,South Korea,Jan. 14,2025-- Premium vegan beauty brandd\'Alba has achieved significant growth in its overseas sales,rising to approximately KRW 150 billion won (USD 100 million) in 2024 - which i

GUIDESJan 15, 2025

XDS Shoes: How to Find a Shoe Manufacturer

JINJIANG,China,Jan. 14,2025-- With the rising demand for high-quality footwear and private-label customization,finding the right shoe manufacturer has become a critical challenge for businesses in the

REVIEWSJan 15, 2025

RuggON Launches VIKING II: Transforming Fleet Management with Unmatched Technology and Flexibility

Powered by Android 14 and Qualcomm® Snapdragon™ 6490 Octa-Core Processor,Engineered for Demanding Fleet Applications

CULTUREJan 15, 2025

LEGO® Education Announces Hands-on Learning Solution for K-8 Science

Hands-on learning helps build confidence,yet only half of students have access to these experiences in science class,according to a new LEGO® Education report. LEGO® Education Science aims to

REVIEWSJan 15, 2025

Cognex Strengthens Market Leadership in Industrial Barcode Reading with Two New AI-Powered Products

DataMan 290 and 390 barcode readers,backed by industry-leading customer support,deliver unmatched reliability and ease of use

TRENDINGJan 15, 2025

MINISO Group Announces Completion of US$550 Million Equity Linked Securities

GUANGZHOU,China,Jan. 14,2025-- MINISO Group Holding Limited (NYSE: MNSO; HKEX: 9896) ("MINISO","MINISO Group" or the "Company"),a global value retailer offering a variety

CULTUREJan 15, 2025

ImmunoForge Receives IND Approval for Phase 2 Clinical Trial of 'Pemziviptadil' for DMD Cardiomyopathy Treatment from FDA, and KF1601, a chronic myeloid leukemia treatment, phase 1 clinical trial IND approved by MFDS

SEOUL,South Korea,Jan. 14,2025-- ImmunoForge announced that it has received approval for the Phase 2 clinical trial IND for \'Pemziviptadil (development code name PF1804),\' a treatment for DMD (Duch

TRENDINGJan 15, 2025

AI must be better integrated into investment process, new buy-side survey by SimCorp shows

Key findings in the 2025 InvestOps report: A new report surveying 200 global buy-side operations leaders reveals that the majority (75%) understand the potential benefits of integrating AI,but need m

TRENDINGJan 15, 2025

LEGO® Education Announces Hands-on Learning Solution for Year 1-10 Science

Hands-on learning helps build confidence,yet only half of students have access to these experiences in science lessons,according to a new LEGO® Education report. LEGO® Education Science aims t

1 ... 466 467 468 469 470 471 472 ... 1317
Navigating the Gaming Realm! Discover a universe of gaming at Pops Games, where we're your expert companions on the journey of gaming culture. From breaking news to in-depth reviews, we are your go-to source for everything gaming, while embracing inclusivity.
© PopsGames Privacy Policy